These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25130427)
21. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α. Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533 [TBL] [Abstract][Full Text] [Related]
22. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Liu H; Zhong H; Yin Y; Jiang Z Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835 [TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [TBL] [Abstract][Full Text] [Related]
24. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686 [TBL] [Abstract][Full Text] [Related]
26. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway. Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185 [TBL] [Abstract][Full Text] [Related]
27. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238 [TBL] [Abstract][Full Text] [Related]
28. Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis. Nussbaum JM; Liu LJ; Hasan SA; Schaub M; McClendon A; Stainier DY; Sakaguchi TF Hepatology; 2013 Oct; 58(4):1326-38. PubMed ID: 23744565 [TBL] [Abstract][Full Text] [Related]
29. Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice. Annunziata C; Lama A; Pirozzi C; Cavaliere G; Trinchese G; Di Guida F; Nitrato Izzo A; Cimmino F; Paciello O; De Biase D; Murru E; Banni S; Calignano A; Mollica MP; Mattace Raso G; Meli R FASEB J; 2020 Jan; 34(1):350-364. PubMed ID: 31914699 [TBL] [Abstract][Full Text] [Related]
30. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Cheng Q; Li YW; Yang CF; Zhong YJ; He H; Zhu FC; Li L Chem Biol Interact; 2018 Aug; 291():180-189. PubMed ID: 29940154 [TBL] [Abstract][Full Text] [Related]
31. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice. Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012 [TBL] [Abstract][Full Text] [Related]
32. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348 [TBL] [Abstract][Full Text] [Related]
33. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786 [TBL] [Abstract][Full Text] [Related]
34. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice. Goetzman ES; Tian L; Wood PA Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal. El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393 [TBL] [Abstract][Full Text] [Related]
36. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model. Kim B; Woo MJ; Park CS; Lee SH; Kim JS; Kim B; An S; Kim SH Phytother Res; 2017 Jan; 31(1):132-139. PubMed ID: 27762456 [TBL] [Abstract][Full Text] [Related]
37. A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis. Peng X; Li J; Wang M; Qu K; Zhu H J Pharmacol Sci; 2019 Jun; 140(2):153-161. PubMed ID: 31253430 [TBL] [Abstract][Full Text] [Related]
38. Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. Brocker CN; Patel DP; Velenosi TJ; Kim D; Yan T; Yue J; Li G; Krausz KW; Gonzalez FJ J Lipid Res; 2018 Nov; 59(11):2140-2152. PubMed ID: 30158201 [TBL] [Abstract][Full Text] [Related]
39. Suppression of Hyperglycemia and Hepatic Steatosis by Black-Soybean-Leaf Extract via Enhanced Adiponectin-Receptor Signaling and AMPK Activation. Li H; Kim UH; Yoon JH; Ji HS; Park HM; Park HY; Jeong TS J Agric Food Chem; 2019 Jan; 67(1):90-101. PubMed ID: 30541285 [TBL] [Abstract][Full Text] [Related]
40. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]